Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,973
Closed -$1.43M 237
2023
Q4
$1.43M Sell
4,973
-2,524
-34% -$688K 0.04% 196
2023
Q3
$2.01M Sell
7,497
-22
-0.3% -$5.49K 0.06% 179
2023
Q2
$1.67M Sell
7,519
-57
-0.8% -$13.2K 0.04% 207
2023
Q1
$1.83M Sell
7,576
-69
-0.9% -$16.9K 0.05% 232
2022
Q4
$2.01M Sell
7,645
-330
-4% -$88.5K 0.05% 238
2022
Q3
$1.79M Sell
7,975
-85,348
-91% -$20.7M 0.05% 264
2022
Q2
$22.7M Sell
93,323
-7,839
-8% -$1.92M 0.54% 62
2022
Q1
$24.5M Sell
101,162
-12,078
-11% -$2.78M 0.5% 65
2021
Q4
$25.5M Buy
113,240
+79,258
+233% +$16.7M 0.46% 67
2021
Q3
$7.23M Hold
33,982
0.14% 174
2021
Q2
$8.28M Sell
33,982
-425
-1% -$105K 0.16% 169
2021
Q1
$8.56M Buy
+34,407
New +$8.21M 0.17% 167

Other funds holding AMGN

NFJ Investment Group's AMGN Position: Q1 2024 in Review

NFJ Investment Group sold out of Amgen (AMGN) in Q1 2024, closing a stake of 4,973 shares — an estimated $1.43M sold.

NFJ Investment Group first reported a position in AMGN in Q1 2021 and held it in 12 quarters. The position peaked at $25.5M in Q4 2021. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • NFJ Investment Group reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • NFJ Investment Group sold 4,973 Amgen shares in Q1 2024, an estimated $1.43M.
  • NFJ Investment Group first reported a position in Amgen in Q1 2021 and held it in 12 quarters.
  • NFJ Investment Group's Amgen position peaked at $25.5M in Q4 2021.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on NFJ Investment Group's 13F filing for Q1 2024, filed 15 May 2024.